Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
NRXP
NRXP
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
NRXP News
EMOCARE: First Passive Monitoring Tool for Depression Launched
2d ago
Newsfilter
NRx Deploys AI-Powered TMS System in Florida Clinic
3d ago
Newsfilter
Multiple Companies See Significant Stock Price Gains
4d ago
NASDAQ.COM
NRx Pharmaceuticals: Significant Upside Potential in Ketamine Market
6d ago
Yahoo Finance
Biotech Investment Environment Improves
May 20 2026
Fool
Analysis of Biotech Companies' Prospects
May 20 2026
NASDAQ.COM
NRx Pharmaceuticals Q1 2026 Earnings Call Insights
May 18 2026
seekingalpha
NRx Pharmaceuticals Q1 Operational Highlights and FDA Progress
May 18 2026
Newsfilter
NRx Pharmaceuticals Reports Q1 Earnings Results
May 18 2026
seekingalpha
NRx Pharmaceuticals Receives FDA Clearance for Depression Clinical Trial
May 07 2026
Newsfilter
Highlights from New to The Street Broadcast
Apr 25 2026
Yahoo Finance
NRx Receives Positive FDA Review Letter for Ketamine ANDA
Apr 22 2026
Newsfilter
NRx Receives Preliminary Label Alignment from FDA for Ketamine Product
Apr 06 2026
Newsfilter
NRx Pharmaceuticals Receives FDA Preliminary Label Alignment
Apr 06 2026
Yahoo Finance
Analysis of NRx Pharmaceuticals' Cash Burn and Market Outlook
Mar 29 2026
Yahoo Finance
NRx Pharmaceuticals Releases FY 2025 Financial Results
Mar 24 2026
seekingalpha
Show More News
